Kenan Akgün
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kenan Akgün has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Deniz Palamar
Department of Physical Medicine and Rehabilitation, Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Istanbul, Türkiye
16 shared publications - Tugce Ozekli Misirlioglu
Department of Physical Medicine and Rehabilitation, Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Istanbul, Türkiye
10 shared publications - Rana Terlemez
Department of Physical Medicine and Rehabilitation, Istanbul University-Cerrahpaşa, 34060 Istanbul, Turkey
9 shared publications - Aylin Rezvani
Department of Physical Medicine and Rehabilitation, Istanbul Medipol University Faculty of Medicine, Istanbul Medipol University, Istanbul, Türkiye
5 shared publications - Lale Altan
Department of Physical Medicine Rehabilitation and Rheumatology, Faculty of Medicine, Uludağ University, Bursa, Turkey
5 shared publications - İlknur Aktaş
Department of Physical Medicine and Rehabilitation, University of Health Sciences, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Türkiye
5 shared publications
Latest Publications
- Open Access
- 18 September 2026
- Published by SAGE Publications in Journal of Back and Musculoskeletal Rehabilitation
Cultural adaptation and psychometric validation of the Turkish version of the social role participation questionnaire in patients with ankylosing spondylitis
Background: Social role participation (RP) is a key outcome in patients with ankylosing spondylitis (AS). The Social Role Participation Questionnaire (SRPQ) assesses RP, its limitations, and satisfaction with performance. Objective: This study aimed to translate and culturally adapt the SRPQ into Turkish and evaluate its validity and reliability in individuals with AS. Methods: The SRPQ was translated and culturally adapted following established guidelines. A total of 129 Turkish-speaking patients with AS were included in this multicenter, cross-sectional study. Internal consistency was evaluated using Cronbach's alpha, and test-retest reliability was assessed using the Intraclass Correlation Coefficient (ICC). Construct validity was evaluated through correlations with the AS Quality of Life (ASQoL) Scale, Short Form Health Survey 36 (SF-36), and the Work Productivity and Activity Impairment (WPAI) scale. Results: The Turkish SRPQ showed good to excellent internal consistency (Cronbach's alpha, 0.734–0.963) and test–retest reliability (ICC, 0.736–0.963). The physical difficulty dimension correlated strongly with the ASQoL ( r = 0.756), WPAI-Q6 ( r = 0.694), and the SF-36 physical functioning score ( r = −0.658) (all p < 0.001). Satisfaction with performance was moderately correlated with the SF-36 physical functioning ( r = 0.556, p < 0.001). Role importance showed weaker yet statistically significant correlations with SF-36 subscales, strongest for physical functioning ( r = 0.373, p < 0.001), mental health ( r = 0.299, p = 0.001), and vitality/energy ( r = 0.272, p = 0.002). Conclusion: The Turkish version of the SRPQ is a valid, reliable, and culturally appropriate instrument for assessing social RP in Turkish-speaking patients with AS.
- 18 September 2026
- Published by SAGE Publications in Journal of Back and Musculoskeletal Rehabilitation
Open AccessCultural adaptation and psychometric validation of the Turkish version of the social role participation questionnaire in patients with ankylosing spondylitis
Background: Social role participation (RP) is a key outcome in patients with ankylosing spondylitis (AS). The Social Role Participation Questionnaire (SRPQ) assesses RP, its limitations, and satisfaction with performance. Objective: This study aimed to translate and culturally adapt the SRPQ into Turkish and evaluate its validity and reliability in individuals with AS. Methods: The SRPQ was translated and culturally adapted following established guidelines. A total of 129 Turkish-speaking patients with AS were included in this multicenter, cross-sectional study. Internal consistency was evaluated using Cronbach's alpha, and test-retest reliability was assessed using the Intraclass Correlation Coefficient (ICC). Construct validity was evaluated through correlations with the AS Quality of Life (ASQoL) Scale, Short Form Health Survey 36 (SF-36), and the Work Productivity and Activity Impairment (WPAI) scale. Results: The Turkish SRPQ showed good to excellent internal consistency (Cronbach's alpha, 0.734–0.963) and test–retest reliability (ICC, 0.736–0.963). The physical difficulty dimension correlated strongly with the ASQoL ( r = 0.756), WPAI-Q6 ( r = 0.694), and the SF-36 physical functioning score ( r = −0.658) (all p < 0.001). Satisfaction with performance was moderately correlated with the SF-36 physical functioning ( r = 0.556, p < 0.001). Role importance showed weaker yet statistically significant correlations with SF-36 subscales, strongest for physical functioning ( r = 0.373, p < 0.001), mental health ( r = 0.299, p = 0.001), and vitality/energy ( r = 0.272, p = 0.002). Conclusion: The Turkish version of the SRPQ is a valid, reliable, and culturally appropriate instrument for assessing social RP in Turkish-speaking patients with AS.
- 27 June 2026
- Published by Elsevier in Archives of Physical Medicine and Rehabilitation
- Vol. 107 (11) , 3171-3179
Comparison of Ultrasound-Guided Lavage and Subacromial Bursa Injection for Calcific Tendinitis: A Prospective, Randomized, Double-Blind Trial
- 27 June 2026
- Published by Elsevier in Archives of Physical Medicine and Rehabilitation
- Vol. 107 (11) , 3171-3179
Comparison of Ultrasound-Guided Lavage and Subacromial Bursa Injection for Calcific Tendinitis: A Prospective, Randomized, Double-Blind Trial
- Open Access
- 25 June 2026
- Published by Baycinar Tibbi Yayincilik in Ağrı - The Journal of The Turkish Society of Algology
- Vol. 38 (3) , 202-204
Repeated botulinum toxin injections for neurogenic thoracic outlet syndrome: A case report
Neurogenic thoracic outlet syndrome (nTOS) is a condition caused by compression of the brachial plexus in the thoracic outlet, often leading to pain and paresthesia. In this article, we report a 34-year-old female patient with chronic nTOS symptoms refractory to prior management. Ultrasound-guided diagnostic blocks of the anterior scalene and pectoralis minor muscles provided significant temporary relief. Subsequent ultrasoundguided onabotulinum toxin A (BTX-A) injections into the scalene muscles resulted in near-complete symptom resolution lasting approximately six months. Over an 18-month follow-up, repeated injections at six-month intervals produced consistent clinical improvement without adverse effects. In conclusion, repeated ultrasound-guided BTX-A injections may be a safe and effective option within a multimodal treatment approach for nTOS.
- 25 June 2026
- Published by Baycinar Tibbi Yayincilik in Ağrı - The Journal of The Turkish Society of Algology
- Vol. 38 (3) , 202-204
Open AccessRepeated botulinum toxin injections for neurogenic thoracic outlet syndrome: A case report
Neurogenic thoracic outlet syndrome (nTOS) is a condition caused by compression of the brachial plexus in the thoracic outlet, often leading to pain and paresthesia. In this article, we report a 34-year-old female patient with chronic nTOS symptoms refractory to prior management. Ultrasound-guided diagnostic blocks of the anterior scalene and pectoralis minor muscles provided significant temporary relief. Subsequent ultrasoundguided onabotulinum toxin A (BTX-A) injections into the scalene muscles resulted in near-complete symptom resolution lasting approximately six months. Over an 18-month follow-up, repeated injections at six-month intervals produced consistent clinical improvement without adverse effects. In conclusion, repeated ultrasound-guided BTX-A injections may be a safe and effective option within a multimodal treatment approach for nTOS.
- Open Access
- 10 June 2026
- Published by Galenos Yayinevi in Turkish Journal of Physical Medicine and Rehabilitation
- Vol. 72 (2) , 188-196
Turkish version of the American Academy of Orofacial Pain screening questionnaire for temporomandibular disorders: Its cross-cultural adaptation, validity, and reliability
Objectives: This study aims to translate and cross-culturally adapt the American Academy of Orofacial Pain (AAOP) screening questionnaire and assess its validity and reliability. Patients and methods: This cross-sectional study included a total of 60 patients (16 males, 44 females; mean age: 50.9±17.3 years; range, 19 to 84 years) admitted to a Physical Medicine And Rehabilitation Outpatient Clinic between January 2016 and June 2016. Backward and forward translation of AAOP questionnaire was performed in both languages. Diagnostic Criteria for Temporomandibular Disorders was used to as a reference standard. Validity was assessed with internal construct and criterion validity. Reliability was evaluated with test-retest reliability and internal consistency. Results: Fifty-seven percent of the patients were classified as having a temporomandibular disorder. The factor analysis yielded three components that explained 63.8% of the variance. The internal consistency of the AAOP questionnaire was acceptable (Cronbach’s alpha value=0.781). The correlation coefficient for the intra- and interrater reliability were found as 0.740 and 0.713, respectively. Conclusion: The Turkish version of the AAOP screening questionnaire is a valid and reliable tool for screening of patients admitted to physical medicine and rehabilitation outpatient clinics with a good internal consistency, intra- and interrater reliability.
- 10 June 2026
- Published by Galenos Yayinevi in Turkish Journal of Physical Medicine and Rehabilitation
- Vol. 72 (2) , 188-196
Open AccessTurkish version of the American Academy of Orofacial Pain screening questionnaire for temporomandibular disorders: Its cross-cultural adaptation, validity, and reliability
Objectives: This study aims to translate and cross-culturally adapt the American Academy of Orofacial Pain (AAOP) screening questionnaire and assess its validity and reliability. Patients and methods: This cross-sectional study included a total of 60 patients (16 males, 44 females; mean age: 50.9±17.3 years; range, 19 to 84 years) admitted to a Physical Medicine And Rehabilitation Outpatient Clinic between January 2016 and June 2016. Backward and forward translation of AAOP questionnaire was performed in both languages. Diagnostic Criteria for Temporomandibular Disorders was used to as a reference standard. Validity was assessed with internal construct and criterion validity. Reliability was evaluated with test-retest reliability and internal consistency. Results: Fifty-seven percent of the patients were classified as having a temporomandibular disorder. The factor analysis yielded three components that explained 63.8% of the variance. The internal consistency of the AAOP questionnaire was acceptable (Cronbach’s alpha value=0.781). The correlation coefficient for the intra- and interrater reliability were found as 0.740 and 0.713, respectively. Conclusion: The Turkish version of the AAOP screening questionnaire is a valid and reliable tool for screening of patients admitted to physical medicine and rehabilitation outpatient clinics with a good internal consistency, intra- and interrater reliability.
- 12 February 2026
- Published by Springer Nature in Clinical Rheumatology
- Vol. 45 (4) , 2319-2327
Evaluation of crystal-related arthritis in patients with knee effusion: insights from ultrasonography, microscopy and radiography
Objectives This study aimed to investigate the prevalence of crystal arthritis in patients with unilateral knee effusion and to evaluate the diagnostic performance of US in comparison with radiography. Methods Patients above 18 years of age presenting with symptomatic unilateral knee effusion were included. Ultrasound of involved knees were performed. Hyperechoic bands within the femoral hyaline cartilage, hyperechoic foci in meniscal fibrocartilage, hyperechoic foci in the effusion and tendon calcifications were recorded as findings of calcium pyrophosphate dehydrate deposition(CPPD) disease and radiographic evaluations were done for searching chondrocalcinosis. SF aspiration was performed for searching crystals microscopically. Microscopic analysis accepted as the gold standard for CPPD, the sensitivity and specificity of US and radiography were assessed. Results Eighty-five patients with a mean age of 60.98 ± 11.95 years were included. None of them had uric acid crystals. CPPD was diagnosed with detecting CPP crystals in SF analysis in 15 of 85 patients. Two of these patients had coexisting rheumatoid arthritis (RA), 1 spondyloarthritis and 12 osteoarthritis. Of the remaining 70 patients, 1 was considered as spondyloarthritis, 4 as RA and 65 as exacerbation of osteoarthritis. The sensitivity and specificity of US were 93.33% and 80%, while radiography demonstrated values of 46.67% and 98.57%, respectively. Inter- and intra-rater agreement for US were 93.3% and 96.67%, respectively. Conclusion A notable 17.6% CPPD prevalence in patients with knee effusion suggests that this condition may be underestimated in practice due to diagnostic challenges. Ultrasound showed higher sensitivity than radiography, and specificity increased in parallel with the number of positive findings. Key Points • In detecting CPPD, ultrasound has higher sensitivity than radiography and specificity increases in parallel with the number of positive findings. • Ultrasound may provide additional diagnostic value when crystal detection with microscopic analysis is challenging.
- 12 February 2026
- Published by Springer Nature in Clinical Rheumatology
- Vol. 45 (4) , 2319-2327
Evaluation of crystal-related arthritis in patients with knee effusion: insights from ultrasonography, microscopy and radiography
Objectives This study aimed to investigate the prevalence of crystal arthritis in patients with unilateral knee effusion and to evaluate the diagnostic performance of US in comparison with radiography. Methods Patients above 18 years of age presenting with symptomatic unilateral knee effusion were included. Ultrasound of involved knees were performed. Hyperechoic bands within the femoral hyaline cartilage, hyperechoic foci in meniscal fibrocartilage, hyperechoic foci in the effusion and tendon calcifications were recorded as findings of calcium pyrophosphate dehydrate deposition(CPPD) disease and radiographic evaluations were done for searching chondrocalcinosis. SF aspiration was performed for searching crystals microscopically. Microscopic analysis accepted as the gold standard for CPPD, the sensitivity and specificity of US and radiography were assessed. Results Eighty-five patients with a mean age of 60.98 ± 11.95 years were included. None of them had uric acid crystals. CPPD was diagnosed with detecting CPP crystals in SF analysis in 15 of 85 patients. Two of these patients had coexisting rheumatoid arthritis (RA), 1 spondyloarthritis and 12 osteoarthritis. Of the remaining 70 patients, 1 was considered as spondyloarthritis, 4 as RA and 65 as exacerbation of osteoarthritis. The sensitivity and specificity of US were 93.33% and 80%, while radiography demonstrated values of 46.67% and 98.57%, respectively. Inter- and intra-rater agreement for US were 93.3% and 96.67%, respectively. Conclusion A notable 17.6% CPPD prevalence in patients with knee effusion suggests that this condition may be underestimated in practice due to diagnostic challenges. Ultrasound showed higher sensitivity than radiography, and specificity increased in parallel with the number of positive findings. Key Points • In detecting CPPD, ultrasound has higher sensitivity than radiography and specificity increases in parallel with the number of positive findings. • Ultrasound may provide additional diagnostic value when crystal detection with microscopic analysis is challenging.
- Open Access
- 19 January 2026
- Published by Springer Nature in Clinical Rheumatology
- Vol. 45 (2) , 945-956
Prevalence and risk factors of difficult-to-treat axial spondyloarthritis: Real-life evidence from the BioSTaR database
Objectives: This study was aimed at determining the prevalence of difficult-to-treat (D2T) axial spondyloarthritis (axSpA) and identifying main associated factors for D2T axSpA. Method: This multicenter observational cross-sectional study included axSpA patients from the BioSTaR (Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs Registry) from February 1, 2019, to January 1, 2025. Data from 1800 axSpA patients who have previously used or are currently using at least one biologic/targeted synthetic disease-modifying antirheumatic drug were analyzed. Patient data included demographic characteristics, body mass index (BMI), marital status, smoking and alcohol use, family history of SpA, and presence of comorbidities. The parameters related to SpA such as disease duration, type of axSpA (radiographic/non-radiographic), HLA-B27 status, the presence of extra-musculoskeletal manifestations (uveitis, psoriasis, and inflammatory bowel disease), arthritis, enthesitis, and dactylitis were also recorded. Comorbidities including hypertension, cardiovascular disease, diabetes, obesity, and hyperlipidemia were recorded, and Charlson Index scores were evaluated. Maastricht Ankylosing Spondylitis Enthesitis Score (MASES) and disease activity in means of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) were also recorded. All medication history and currently used medications for axSpA and other diseases were noted. D2T and non-D2T axSpA patients were classified according to the suggested extrapolated definition. Results: Of the 1800 axSpA patients recorded in the BioSTaR database, 204 (11.3%) were classified as D2T axSpA. Data of these patients were compared to the data from 1596 non-D2T axSpA patients. Disease duration was longer in D2T patients ( p = 0.025). The presence of radiographic disease was more frequent in the D2T group ( p = 0.047). In means of MASES and ASDAS-CRP, higher scores were recorded in the D2T group (both p < 0.001). Enthesitis and psoriasis were more frequent in the D2T group ( p = 0.002 and p = 0.006). Regarding comorbidities, hypertension and cardiovascular diseases were more frequent in the D2T group ( p < 0.001 and p = 0.009). The risk of D2T axSpA increased 2.37-fold with the presence of r-axSpA ( p = 0.018), 1.92-fold with the presence of hypertension ( p = 0.006), 2.12-fold with the presence of obesity ( p = 0.024), and 3.63-fold with the presence of psoriasis ( p = 0.004). Every 1-point increase in MASES increased D2T risk 1.08-fold ( p = 0.017), and every 1-point increase in ASDAS-CRP increased D2T risk 1.62-fold ( p < 0.001). Conclusions: In conclusion, 11.3% of patients with axSpA met the proposed criteria for D2T axSpA. This subgroup was characterized by longer disease duration, higher frequency of r-axSpA, enthesitis, and psoriasis, as well as elevated MASES, CRP, ASDAS-CRP, and BASDAI scores. Hypertension and cardiovascular comorbidities were also significantly more prevalent among D2T patients. These parameters represent potential contributors to treatment complexity and should be carefully considered in therapeutic decision-making. In cases of suboptimal treatment response, reassessment and optimal management of comorbidities are essential, as comorbid conditions can increase disease burden and diminish therapeutic efficacy. Comprehensive care for axSpA should therefore include targeted management of accompanying comorbidities in parallel with disease-specific therapy. Monitoring blood pressure, optimizing body weight, and encouraging smoking cessation are particularly important. Additionally, concomitant rheumatic diseases such as psoriasis, uveitis, or inflammatory bowel disease should be actively evaluated and treated, given their association with more severe disease and reduced treatment response. Key Points • Prospectively collected data of 1800 axial spondyloarthritis patients were assessed for this cross-sectional study .• 11.3% of axial spondyloarthritis patients were identified as difficult-to-treat .• Longer disease duration and presence of radiographic axial spondyloarthritis, enthesitis, and psoriasis are more prevalent in difficult-to-treat axial spondyloarthritis patients .• Factors and comorbidities complicating axial spondyloarthritis treatment should be considered in treatment plans .
- 19 January 2026
- Published by Springer Nature in Clinical Rheumatology
- Vol. 45 (2) , 945-956
Open AccessPrevalence and risk factors of difficult-to-treat axial spondyloarthritis: Real-life evidence from the BioSTaR database
Objectives: This study was aimed at determining the prevalence of difficult-to-treat (D2T) axial spondyloarthritis (axSpA) and identifying main associated factors for D2T axSpA. Method: This multicenter observational cross-sectional study included axSpA patients from the BioSTaR (Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs Registry) from February 1, 2019, to January 1, 2025. Data from 1800 axSpA patients who have previously used or are currently using at least one biologic/targeted synthetic disease-modifying antirheumatic drug were analyzed. Patient data included demographic characteristics, body mass index (BMI), marital status, smoking and alcohol use, family history of SpA, and presence of comorbidities. The parameters related to SpA such as disease duration, type of axSpA (radiographic/non-radiographic), HLA-B27 status, the presence of extra-musculoskeletal manifestations (uveitis, psoriasis, and inflammatory bowel disease), arthritis, enthesitis, and dactylitis were also recorded. Comorbidities including hypertension, cardiovascular disease, diabetes, obesity, and hyperlipidemia were recorded, and Charlson Index scores were evaluated. Maastricht Ankylosing Spondylitis Enthesitis Score (MASES) and disease activity in means of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) were also recorded. All medication history and currently used medications for axSpA and other diseases were noted. D2T and non-D2T axSpA patients were classified according to the suggested extrapolated definition. Results: Of the 1800 axSpA patients recorded in the BioSTaR database, 204 (11.3%) were classified as D2T axSpA. Data of these patients were compared to the data from 1596 non-D2T axSpA patients. Disease duration was longer in D2T patients ( p = 0.025). The presence of radiographic disease was more frequent in the D2T group ( p = 0.047). In means of MASES and ASDAS-CRP, higher scores were recorded in the D2T group (both p < 0.001). Enthesitis and psoriasis were more frequent in the D2T group ( p = 0.002 and p = 0.006). Regarding comorbidities, hypertension and cardiovascular diseases were more frequent in the D2T group ( p < 0.001 and p = 0.009). The risk of D2T axSpA increased 2.37-fold with the presence of r-axSpA ( p = 0.018), 1.92-fold with the presence of hypertension ( p = 0.006), 2.12-fold with the presence of obesity ( p = 0.024), and 3.63-fold with the presence of psoriasis ( p = 0.004). Every 1-point increase in MASES increased D2T risk 1.08-fold ( p = 0.017), and every 1-point increase in ASDAS-CRP increased D2T risk 1.62-fold ( p < 0.001). Conclusions: In conclusion, 11.3% of patients with axSpA met the proposed criteria for D2T axSpA. This subgroup was characterized by longer disease duration, higher frequency of r-axSpA, enthesitis, and psoriasis, as well as elevated MASES, CRP, ASDAS-CRP, and BASDAI scores. Hypertension and cardiovascular comorbidities were also significantly more prevalent among D2T patients. These parameters represent potential contributors to treatment complexity and should be carefully considered in therapeutic decision-making. In cases of suboptimal treatment response, reassessment and optimal management of comorbidities are essential, as comorbid conditions can increase disease burden and diminish therapeutic efficacy. Comprehensive care for axSpA should therefore include targeted management of accompanying comorbidities in parallel with disease-specific therapy. Monitoring blood pressure, optimizing body weight, and encouraging smoking cessation are particularly important. Additionally, concomitant rheumatic diseases such as psoriasis, uveitis, or inflammatory bowel disease should be actively evaluated and treated, given their association with more severe disease and reduced treatment response. Key Points • Prospectively collected data of 1800 axial spondyloarthritis patients were assessed for this cross-sectional study .• 11.3% of axial spondyloarthritis patients were identified as difficult-to-treat .• Longer disease duration and presence of radiographic axial spondyloarthritis, enthesitis, and psoriasis are more prevalent in difficult-to-treat axial spondyloarthritis patients .• Factors and comorbidities complicating axial spondyloarthritis treatment should be considered in treatment plans .
- 8 September 2025
- Published by Springer Nature in Rheumatology International
- Vol. 45 (9) , 1-10
The impact of obesity and overweight on rheumatoid arthritis patients: real-world insights from a biologic and targeted synthetic DMARDs registry
The Impact of Obesity and Overweight on Rheumatoid Arthritis Patients: Real-World Insights from a Biologic and Targeted Synthetic DMARDs Registry. The management of rheumatoid arthritis (RA) has advanced with biological and targeted synthetic disease-modifying anti-rheumatic drugs (b/tsDMARDs). However, obesity, a common comorbidity, impacts treatment and disease progression efficacy. This article examines the association between body weight, activity of the disease and the effectiveness of b/tsDMARDs in RA patients. This multicenter observational cohort study, conducted as part of the BioSTAR Registry, involved a total of 856 patients diagnosed with RA (168 males and 688 females). Patients were separated into groups based on BMI: Group 1 (“normal BMI: ≥18.5 to < 25 kg/m2 or underweight BMI: 2”) and Group 2 (“overweight BMI: ≥25 to < 30 kg/m2 or obese BMI: ≥30 kg/m2”). Baseline socio-demographic and clinical data, medication use, switching status, and total glucocorticoid dose (mg-year) were collected. Age, disease duration, disease activity scores were considerably higher in obesity/overweight patients. Remission rates were lower in obese/overweight patients (35.6% and 25.9% in group 1 and 2 respectively; p = 0.026). The cumulative steroid doses, number of biologics and switches were similar between groups, regardless of pharmacological mechanisms. Regression analysis indicated that BMI was one of the factors affecting DAS28-CRP. The obesity/overweight rate is as high as 70.4% in RA patients. While obesity/overweight is related to enhanced disease activity, lower remission rates in RA, its effect on the choice and switch rates of b/tsDMARDs appears minimal. Clinical effectiveness remains consistent across drug classes, regardless of BMI.
- 8 September 2025
- Published by Springer Nature in Rheumatology International
- Vol. 45 (9) , 1-10
The impact of obesity and overweight on rheumatoid arthritis patients: real-world insights from a biologic and targeted synthetic DMARDs registry
The Impact of Obesity and Overweight on Rheumatoid Arthritis Patients: Real-World Insights from a Biologic and Targeted Synthetic DMARDs Registry. The management of rheumatoid arthritis (RA) has advanced with biological and targeted synthetic disease-modifying anti-rheumatic drugs (b/tsDMARDs). However, obesity, a common comorbidity, impacts treatment and disease progression efficacy. This article examines the association between body weight, activity of the disease and the effectiveness of b/tsDMARDs in RA patients. This multicenter observational cohort study, conducted as part of the BioSTAR Registry, involved a total of 856 patients diagnosed with RA (168 males and 688 females). Patients were separated into groups based on BMI: Group 1 (“normal BMI: ≥18.5 to < 25 kg/m2 or underweight BMI: 2”) and Group 2 (“overweight BMI: ≥25 to < 30 kg/m2 or obese BMI: ≥30 kg/m2”). Baseline socio-demographic and clinical data, medication use, switching status, and total glucocorticoid dose (mg-year) were collected. Age, disease duration, disease activity scores were considerably higher in obesity/overweight patients. Remission rates were lower in obese/overweight patients (35.6% and 25.9% in group 1 and 2 respectively; p = 0.026). The cumulative steroid doses, number of biologics and switches were similar between groups, regardless of pharmacological mechanisms. Regression analysis indicated that BMI was one of the factors affecting DAS28-CRP. The obesity/overweight rate is as high as 70.4% in RA patients. While obesity/overweight is related to enhanced disease activity, lower remission rates in RA, its effect on the choice and switch rates of b/tsDMARDs appears minimal. Clinical effectiveness remains consistent across drug classes, regardless of BMI.
- Open Access
- 31 October 2024
- Published by Galenos Yayinevi in Turkish Journal of Physical Medicine and Rehabilitation
- Vol. 70 (4) , 525-531
Sensitivity and specificity assessment of four clinical tests for palmaris longus muscle by ultrasound
Objectives: This study aimed to evaluate the accuracy of four clinical tests confirmed by ultrasonography (USG) and to evaluate the role of age, sex, handedness, subcutaneous tissue thickness (STT), tendon thickness (TT), and STT/TT in determining the absence of the palmaris longus muscle. Patients and methods: In this descriptive study, 282 wrists of 141 healthy individuals (71 females, 70 males; mean age: 29±9.6 years; range, 21 to 55 years) were included between September 2021 and November 2022. The palmaris longus muscle tendon was identified by Schaeffer’s test, Mishra’s test I, Thompson’s test, and Pushpakumar’s test and then evaluated with USG. Before the tests, age, sex, and dominant hand information of the individuals were obtained. The STT and TT were measured with USG. Results: Sensitivity values by side were as follows (right/left respectively): Schaeffer’s 92%/73%, Mishra’s I 91%/93%, Thompson’s 84%/87%, and Pushpakumar’s 86%/91%. Specificity values by side were as follows (right/left respectively): Schaeffer’s 87%/95%, Mishra’s I 78%/82%, Thompson’s 78%/79%, and Pushpakumar’s 84%/82%. Sensitivity values by sex were as follows (female/male respectively): Schaeffer’s 81%/96%, Mishra’s I 92%/94%, Thompson’s 85%/90%, and Pushpakumar’s 91%/92%. Specificity values by sex were as follows (female/male respectively): Schaeffer’s 68%/90%, Mishra’s I 72%/90%, Thompson’s 72%/85%, and Pushpakumar’s 78%/85%. The intraclass correlation coefficient between clinical tests and USG was 0.94 for the left side and 0.95 for the right side. Conclusion: Mishra’s test I and Pushpakumar’s test can be used in females, while Schaeffer's test and Mishra’s test I can be used in males as a mutually supportive clinical test. Furthermore, while there may be false negative and false positive test results due to muscle variations, it should be noted that STT/TT is also effective, particularly on the right side.
- 31 October 2024
- Published by Galenos Yayinevi in Turkish Journal of Physical Medicine and Rehabilitation
- Vol. 70 (4) , 525-531
Open AccessSensitivity and specificity assessment of four clinical tests for palmaris longus muscle by ultrasound
Objectives: This study aimed to evaluate the accuracy of four clinical tests confirmed by ultrasonography (USG) and to evaluate the role of age, sex, handedness, subcutaneous tissue thickness (STT), tendon thickness (TT), and STT/TT in determining the absence of the palmaris longus muscle. Patients and methods: In this descriptive study, 282 wrists of 141 healthy individuals (71 females, 70 males; mean age: 29±9.6 years; range, 21 to 55 years) were included between September 2021 and November 2022. The palmaris longus muscle tendon was identified by Schaeffer’s test, Mishra’s test I, Thompson’s test, and Pushpakumar’s test and then evaluated with USG. Before the tests, age, sex, and dominant hand information of the individuals were obtained. The STT and TT were measured with USG. Results: Sensitivity values by side were as follows (right/left respectively): Schaeffer’s 92%/73%, Mishra’s I 91%/93%, Thompson’s 84%/87%, and Pushpakumar’s 86%/91%. Specificity values by side were as follows (right/left respectively): Schaeffer’s 87%/95%, Mishra’s I 78%/82%, Thompson’s 78%/79%, and Pushpakumar’s 84%/82%. Sensitivity values by sex were as follows (female/male respectively): Schaeffer’s 81%/96%, Mishra’s I 92%/94%, Thompson’s 85%/90%, and Pushpakumar’s 91%/92%. Specificity values by sex were as follows (female/male respectively): Schaeffer’s 68%/90%, Mishra’s I 72%/90%, Thompson’s 72%/85%, and Pushpakumar’s 78%/85%. The intraclass correlation coefficient between clinical tests and USG was 0.94 for the left side and 0.95 for the right side. Conclusion: Mishra’s test I and Pushpakumar’s test can be used in females, while Schaeffer's test and Mishra’s test I can be used in males as a mutually supportive clinical test. Furthermore, while there may be false negative and false positive test results due to muscle variations, it should be noted that STT/TT is also effective, particularly on the right side.
- Open Access
- 30 June 2024
- Published by AVES YAYINCILIK A.Ş. in Archives of Rheumatology
- Vol. 39 (2) , 242-254
The relationship between clinical parameters and ultrasonographic enthesitis assessment in patients with spondyloarthritis
Objectives: The study aimed to evaluate the role of ultrasonographic assessment of enthesitis in patients with spondyloarthritis (SpA) in terms of disease activity, functionality, and quality of life. Patients and methods: Ninety SpA patients (57 males, 33 females; mean age: 37.5±9.7 years; range, 18 to 60 years) were included in cross-sectional study between November 2016 and January 2017. Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Ankylosing Spondylitis Disease Activity Score (ASDAS), Bath Ankylosing Spondylitis Functional Index (BASFI), Short Form-12 (SF-12), and Ankylosing Spondylitis Quality of Life (ASQoL) were utilized for clinical evaluation. The clinical evaluation of enthesitis was performed with the Spondyloarthritis Research Consortium of Canada (SPARCC) and Maastricht Ankylosing Spondylitis Enthesitis Score (MASES) via an algometer calibrated to 4 kg/cm2 of pressure. Ultrasound evaluation was performed according to Madrid Sonographic Enthesitis Index (MASEI). A total of 2,610 entheseal sites were examined clinically, and 1,080 were assessed ultrasonographically. Results: A significant proportion of enthesitis (463/1,080) was detected on ultrasonographic evaluation but not with clinical enthesitis score (MASES and SPARCC). Although ultrasonographic entheseal evaluation detected enthesitis in at least one enthesis of all patients, 35 of the patients had no enthesitis with clinical examination. The sites most frequently involved in the entheses were the proximal patellar tendon and Achilles tendon. The MASEI score did not correlate with the MASES, SPARCC, BASDAI, SF-12, and ASQoL but moderately correlated with the C-reactive protein (CRP) level (r=0.348), ASDAS-CRP (r=0.294), and BASFI score (r=0.244). Conclusion: The association of ultrasonography scores with CRP levels and ASDAS-CRP indicates that ultrasonography is effective in detecting inflammation. The MASEI score weakly correlates with functionality but not with quality of life. Ultrasonographic evaluation is invaluable and merits to be incorporated into SpA disease scoring system.
- 30 June 2024
- Published by AVES YAYINCILIK A.Ş. in Archives of Rheumatology
- Vol. 39 (2) , 242-254
Open AccessThe relationship between clinical parameters and ultrasonographic enthesitis assessment in patients with spondyloarthritis
Objectives: The study aimed to evaluate the role of ultrasonographic assessment of enthesitis in patients with spondyloarthritis (SpA) in terms of disease activity, functionality, and quality of life. Patients and methods: Ninety SpA patients (57 males, 33 females; mean age: 37.5±9.7 years; range, 18 to 60 years) were included in cross-sectional study between November 2016 and January 2017. Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Ankylosing Spondylitis Disease Activity Score (ASDAS), Bath Ankylosing Spondylitis Functional Index (BASFI), Short Form-12 (SF-12), and Ankylosing Spondylitis Quality of Life (ASQoL) were utilized for clinical evaluation. The clinical evaluation of enthesitis was performed with the Spondyloarthritis Research Consortium of Canada (SPARCC) and Maastricht Ankylosing Spondylitis Enthesitis Score (MASES) via an algometer calibrated to 4 kg/cm2 of pressure. Ultrasound evaluation was performed according to Madrid Sonographic Enthesitis Index (MASEI). A total of 2,610 entheseal sites were examined clinically, and 1,080 were assessed ultrasonographically. Results: A significant proportion of enthesitis (463/1,080) was detected on ultrasonographic evaluation but not with clinical enthesitis score (MASES and SPARCC). Although ultrasonographic entheseal evaluation detected enthesitis in at least one enthesis of all patients, 35 of the patients had no enthesitis with clinical examination. The sites most frequently involved in the entheses were the proximal patellar tendon and Achilles tendon. The MASEI score did not correlate with the MASES, SPARCC, BASDAI, SF-12, and ASQoL but moderately correlated with the C-reactive protein (CRP) level (r=0.348), ASDAS-CRP (r=0.294), and BASFI score (r=0.244). Conclusion: The association of ultrasonography scores with CRP levels and ASDAS-CRP indicates that ultrasonography is effective in detecting inflammation. The MASEI score weakly correlates with functionality but not with quality of life. Ultrasonographic evaluation is invaluable and merits to be incorporated into SpA disease scoring system.
- 7 June 2024
- Published by Wiley in Pain Practice
- Vol. 24 (8) , 989-996
The frequency of superior cluneal nerve entrapment diagnosed with ultrasound‐guided nerve block in patients with low back pain: A prospective, cross‐sectional study
Introduction: To determine the frequency of superior cluneal nerve entrapment (SCN‐E) in patients who applied to our outpatient clinic with low back pain.Methods: Two hundred patients with mechanical low back pain persisting more than 3 months were included in our study. All patients were evaluated with detailed clinical history and physical examination. Ultrasound‐guided diagnostic injection was performed in patients who had tenderness on the posterior iliac crest and whose main complaint emerged by pressing on this point. Patients with 70% or greater pain relief 1 h after the injection were considered as SCN‐E. The frequency and clinical features of SCN‐E were determined and compared with other mechanical low back pain.Results: The mean age of the patients included in our study was 48.56 ± 14.11 years, with 138 female and 62 male patients. The diagnostic injection was performed on 31 patients and considered positive in 24 of them. The frequency of SCN‐E was determined as 12%. The Hip‐Knee Flexion Test was determined to be more specific for SCN‐E than other causes of low back pain, the sensitivity and specificity of the test were 41.67% and 88.64% (p = 0.001; p < 0.01). In addition, all demographic and clinical features in patients diagnosed with SCN‐E were found to be similar to other mechanical low back pain cases.Conclusions: In patients with chronic low back pain, SCN‐E is not a rare cause and is often overlooked. Increasing the awareness and experience of physicians on SCN‐E will prevent patients from being exposed to unnecessary surgical or non‐surgical treatments.
- 7 June 2024
- Published by Wiley in Pain Practice
- Vol. 24 (8) , 989-996
The frequency of superior cluneal nerve entrapment diagnosed with ultrasound‐guided nerve block in patients with low back pain: A prospective, cross‐sectional study
Introduction: To determine the frequency of superior cluneal nerve entrapment (SCN‐E) in patients who applied to our outpatient clinic with low back pain.Methods: Two hundred patients with mechanical low back pain persisting more than 3 months were included in our study. All patients were evaluated with detailed clinical history and physical examination. Ultrasound‐guided diagnostic injection was performed in patients who had tenderness on the posterior iliac crest and whose main complaint emerged by pressing on this point. Patients with 70% or greater pain relief 1 h after the injection were considered as SCN‐E. The frequency and clinical features of SCN‐E were determined and compared with other mechanical low back pain.Results: The mean age of the patients included in our study was 48.56 ± 14.11 years, with 138 female and 62 male patients. The diagnostic injection was performed on 31 patients and considered positive in 24 of them. The frequency of SCN‐E was determined as 12%. The Hip‐Knee Flexion Test was determined to be more specific for SCN‐E than other causes of low back pain, the sensitivity and specificity of the test were 41.67% and 88.64% (p = 0.001; p < 0.01). In addition, all demographic and clinical features in patients diagnosed with SCN‐E were found to be similar to other mechanical low back pain cases.Conclusions: In patients with chronic low back pain, SCN‐E is not a rare cause and is often overlooked. Increasing the awareness and experience of physicians on SCN‐E will prevent patients from being exposed to unnecessary surgical or non‐surgical treatments.